These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 19127489)
1. The relationship between dysglycemia and cognitive dysfunction. Cukierman-Yaffee T Curr Opin Investig Drugs; 2009 Jan; 10(1):70-4. PubMed ID: 19127489 [TBL] [Abstract][Full Text] [Related]
2. Altered glycemia and brain-update and potential relevance to the aging brain. McCall AL Neurobiol Aging; 2005 Dec; 26 Suppl 1():70-5. PubMed ID: 16198444 [TBL] [Abstract][Full Text] [Related]
3. Insulin resistance in the brain: an old-age or new-age problem? Williamson R; McNeilly A; Sutherland C Biochem Pharmacol; 2012 Sep; 84(6):737-45. PubMed ID: 22634336 [TBL] [Abstract][Full Text] [Related]
4. [Cerebral complications of diabetes mellitus]. Aszalós Z Orv Hetil; 2007 Dec; 148(50):2371-6. PubMed ID: 18055361 [TBL] [Abstract][Full Text] [Related]
5. Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes. Sima AA; Kamiya H; Li ZG Eur J Pharmacol; 2004 Apr; 490(1-3):187-97. PubMed ID: 15094085 [TBL] [Abstract][Full Text] [Related]
6. Cognitive dysfunction in patients with type 2 diabetes. Reijmer YD; van den Berg E; Ruis C; Kappelle LJ; Biessels GJ Diabetes Metab Res Rev; 2010 Oct; 26(7):507-19. PubMed ID: 20799243 [TBL] [Abstract][Full Text] [Related]
7. [The impact of dysglycemia on brain function in children with type 1 diabetes mellitus]. Pańkowska E Med Wieku Rozwoj; 2012; 16(1):5-9. PubMed ID: 22516768 [TBL] [Abstract][Full Text] [Related]
8. Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes. Wessels AM; Scheltens P; Barkhof F; Heine RJ Eur J Pharmacol; 2008 May; 585(1):88-96. PubMed ID: 18396273 [TBL] [Abstract][Full Text] [Related]
9. Links between cognitive impairment in insulin resistance: an explanatory model. Convit A Neurobiol Aging; 2005 Dec; 26 Suppl 1():31-5. PubMed ID: 16246463 [TBL] [Abstract][Full Text] [Related]
10. Insulin and neurodegenerative disease: shared and specific mechanisms. Craft S; Watson GS Lancet Neurol; 2004 Mar; 3(3):169-78. PubMed ID: 14980532 [TBL] [Abstract][Full Text] [Related]
11. Exacerbation of poststroke dementia by type 2 diabetes is associated with synergistic increases of beta-secretase activation and beta-amyloid generation in rat brains. Zhang T; Pan BS; Zhao B; Zhang LM; Huang YL; Sun FY Neuroscience; 2009 Jul; 161(4):1045-56. PubMed ID: 19376202 [TBL] [Abstract][Full Text] [Related]
12. Cellular and metabolic alterations in the hippocampus caused by insulin signalling dysfunction and its association with cognitive impairment during aging and Alzheimer's disease: studies in animal models. Calvo-Ochoa E; Arias C Diabetes Metab Res Rev; 2015 Jan; 31(1):1-13. PubMed ID: 24464982 [TBL] [Abstract][Full Text] [Related]
14. [Diabetes mellitus and cognition: is there a link?]. Barrou Z; Lemaire A; Boddaert J; Verny M Psychol Neuropsychiatr Vieil; 2008 Sep; 6(3):189-98. PubMed ID: 18786878 [TBL] [Abstract][Full Text] [Related]
15. Diabetes, dysglycemia and cognitive dysfunction. Cukierman-Yaffe T Diabetes Metab Res Rev; 2014 Jul; 30(5):341-5. PubMed ID: 24339052 [TBL] [Abstract][Full Text] [Related]
16. Searching for the origin of brain dysfunction in diabetic children: going back to the beginning. Ryan CM Pediatr Diabetes; 2008 Dec; 9(6):527-30. PubMed ID: 19067890 [No Abstract] [Full Text] [Related]
17. Vascular risk factors and cognitive decline among elderly male twins. Gotkine M Neurology; 2007 May; 68(21):1871; author reply 1871. PubMed ID: 17515556 [No Abstract] [Full Text] [Related]
18. Diabetes, hyperglycemia and the management of cerebrovascular disease. Haratz S; Tanne D Curr Opin Neurol; 2011 Feb; 24(1):81-8. PubMed ID: 21124220 [TBL] [Abstract][Full Text] [Related]
19. Insulin resistance and cognitive dysfunction. Ma L; Wang J; Li Y Clin Chim Acta; 2015 Apr; 444():18-23. PubMed ID: 25661087 [TBL] [Abstract][Full Text] [Related]
20. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities. Resmini E; Minuto F; Colao A; Ferone D Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]